NEW YORK, Sept. 16, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ:TGTX).
Read more at prnewswire.comTGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here